Performa LTD (Us), LLC Coh Bar, Inc. Transaction History

Performa LTD (Us), LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$1.53 - $5.01 $3,060 - $10,020	-2,000 Reduced 45.81%	2,366 $6,000
Q4 2022 Feb 03, 2023	BUY	$1.51 - $3.4 $1,057 - $2,380	700 Added 19.09%	4,366 $7,000
Q3 2022 Nov 09, 2022	SELL	$0.17 - $5.25 $6,261 - $193,383	-36,835 Reduced 90.95%	3,666 $11,000
Q2 2022 Aug 02, 2022	BUY	$0.17 - $0.34 $4,165 - $8,330	24,501 Added 153.13%	40,501 $8,000
Q1 2022 May 13, 2022	BUY	$0.25 - $0.43 $1,750 - $3,010	7,000 Added 77.78%	16,000 $5,000
Q4 2021 Jan 31, 2022	BUY	$0.34 - $1.0 $3,060 - $9,000	9,000 New	9,000 $3,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.45M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Performa LTD (Us), LLC, based on Form 13F filings with the SEC.

Stay updated on Performa LTD (Us), LLC with notifications on news.